Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype.

Haematologica
Tadayuki AkagiH Phillip Koeffler

Abstract

Acute myeloid leukemia is a clonal hematopoietic malignant disease; about 45-50% of cases do not have detectable chromosomal abnormalities. Here, we identified hidden genomic alterations and novel disease-related regions in normal karyotype acute myeloid leukemia/myelodysplastic syndrome samples. Thirty-eight normal karyotype acute myeloid leukemia/myelodysplastic syndrome samples were analyzed with high-density single-nucleotide polymorphism microarray using a new algorithm: allele-specific copy-number analysis using anonymous references (AsCNAR). Expression of mRNA in these samples was determined by mRNA microarray analysis. Eighteen samples (49%) showed either one or more genomic abnormalities including duplication, deletion and copy-number neutral loss of heterozygosity. Importantly, 12 patients (32%) had copy-number neutral loss of heterozygosity, causing duplication of either mutant FLT3 (2 cases), JAK2 (1 case) or AML1/RUNX1 (1 case); and each had loss of the normal allele. Nine patients (24%) had small copy-number changes (< 10 Mb) including deletions of NF1, ETV6/TEL, CDKN2A and CDKN2B. Interestingly, mRNA microarray analysis showed a relationship between chromosomal changes and mRNA expression levels: loss or gain of ...Continue Reading

References

Aug 15, 2002·Blood·D Gary Gilliland, James D Griffin
Aug 27, 2002·Annual Review of Genomics and Human Genetics·Louise M Kelly, D Gary Gilliland
May 25, 2004·Oncogene·Luke F Peterson, Dong-Er Zhang
May 25, 2004·Oncogene·Katsuya ShigesadaP Paul Liu
Jan 22, 2005·The New England Journal of Medicine·Brunangelo FaliniUNKNOWN GIMEMA Acute Leukemia Working Party
Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Apr 5, 2005·Oncogene·Sahar Barjesteh van Waalwijk van Doorn-KhosrovaniRuud Delwel
May 10, 2005·Blood·Torsten HaferlachClaudia Schoch
Jul 15, 2005·Genes, Chromosomes & Cancer·Tatiana Alessandra GorlettaPier Paolo Di Fiore
Sep 20, 2005·Cancer Cell·Chi V DangTarja Juopperi
Mar 22, 2006·Oncogene·L J EngleJ E Landers
Nov 28, 2006·Lancet·Elihu Estey, Hartmut Döhner
Jan 19, 2007·Haematologica·Thomas IllmerUNKNOWN DSIL2003 AML study group
Mar 9, 2007·Nature·Charles G MullighanJames R Downing
May 29, 2008·Genes, Chromosomes & Cancer·Manu GuptaBryan D Young

❮ Previous
Next ❯

Citations

Jan 16, 2010·Current Opinion in Hematology·Elizabeth A Eklund
Sep 1, 2012·Annual Review of Pathology·R Coleman Lindsley, Benjamin L Ebert
Jan 19, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zuzana TothovaBenjamin L Ebert
Sep 7, 2011·Cytogenetic and Genome Research·L T van der Veken, A Buijs
Jun 6, 2014·Leukemia & Lymphoma·Matthew KuHarshal Nandurkar
Nov 18, 2010·Expert Review of Molecular Diagnostics·Christopher D Watt, Adam Bagg
Feb 1, 2012·Seminars in Oncology·Aiko Sato-OtsuboSeishi Ogawa
Mar 23, 2011·Seminars in Oncology·Lucy A GodleyMichelle M Le Beau
Aug 12, 2009·International Journal of Cancer. Journal International Du Cancer·Tadayuki AkagiH Phillip Koeffler
Jun 3, 2009·International Journal of Laboratory Hematology·C G Mullighan
Mar 6, 2013·American Journal of Hematology·Elise Boudry-LabisUNKNOWN French ALFA group
Nov 17, 2015·Cell Death Discovery·Alexander S WatsonAnna Katharina Simon
Apr 23, 2011·Cell Cycle·Alexander Scarth WatsonAnna Katharina Simon
Nov 22, 2011·Journal of the Egyptian National Cancer Institute·Neemat KassemOlfat Shaker
Mar 15, 2011·Blood·Paul Spencer HoleAlex Tonks
Nov 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jun Ho YiDong Hwan Kim
May 10, 2020·Current Hematologic Malignancy Reports·Arash RonaghyRashmi Kanagal-Shamanna
Oct 24, 2018·International Journal of Molecular Sciences·Simone FeursteinGudrun Göhring
Feb 14, 2015·Applied Immunohistochemistry & Molecular Morphology : AIMM·Junaid Baqai, Domnita Crisan
Aug 4, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher J WalkerClara D Bloomfield

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.